miR-126 inhibits growth of SGC-7901 cells by synergistically targeting the oncogenes PI3KR2 and Crk, and the tumor suppressor PLK2

International Journal of Oncology

Volumn 45, Issue 3, 2014, Pages 1257-1265

  Liu, Li Ying ^a   Wang, Wei ^b   Zhao, Lin Yu ^a   Guo, Bo ^a   Yang, Juan ^a   Zhao, Xiao Ge ^a   Hou, Ni ^a   Ni, Lei ^a   Wang, Ai Ying ^a   Song, Tu Sheng ^a   Huang, Chen ^a   Xu, Ji Ru ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Crk; MiR 126; PI3KR2; PLK2; Proliferation; Sgc 7901 cells

Indexed keywords

MICRORNA 126; MICRORNA; MIRN126 MICRORNA, HUMAN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PLK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER TISSUE; CELL GROWTH; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; CRK GENE; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; ONCOGENE; PI3KR2 GENE; PLK2 GENE; PRIORITY JOURNAL; STOMACH CANCER; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; ANIMAL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; NUDE MOUSE; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; NEOPLASMS, EXPERIMENTAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-CRK; STOMACH NEOPLASMS;

EID: 84904389111     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2516     Document Type: Article

References (35)

1. Li M, Li J, Ding X, He M and Cheng S: microRNA and cancer. AAPS J 12: 309-317, 2010.
2. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
3. Iorio MV and Croce CM: MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27: 5848-5856, 2009.
4. Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773, 2005. (Pubitemid 40292988)
5. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
6. Kim YK, Yu J, Han TS, et al: Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37: 1672-1681, 2009.
7. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739, 2002. (Pubitemid 34455427)
8. Fish JE, Santoro MM, Morton SU, et al: miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 15: 272-284, 2008.
9. Wang S, Aurora AB, Johnson BA, et al: The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 15: 261-271, 2008.
10. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
11. Cho WC, Chow AS and Au JS: Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur J Cancer 45: 2197-2206, 2009.
12. Feng R, Chen X, Yu Y, et al: miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 298: 50-63, 2010.
13. Otsubo T, Akiyama Y, Hashimoto Y, Shimada S, Goto K and Yuasa Y: MicroRNA-126 inhibits SOX2 expression and contributes to gastric carcinogenesis. PLoS One 6: e16617, 2011.
14. Wang X, Tang S, Le SY, et al: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557, 2008.
15. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC and Liang G: Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 379: 726-731, 2009.
16. Liu S, Gao S, Wang XY and Wang DB: Expression of miR-126 and Crk in endometriosis: miR-126 may affect the progression of endometriosis by regulating Crk expression. Arch Gynecol Obstet 285: 1065-1072, 2012.
17. Meister J and Schmidt MH: miR-126 and miR-126*: new players in cancer. Sci World J 10: 2090-2100, 2010.
18. Sessa R, Seano G, di Blasio L, et al: The miR-126 regulates angiopoietin-1 signaling and vessel maturation by targeting p85beta. Biochim Biophys Acta 1823: 1925-1935, 2012.
19. Zhang J, Du YY, Lin YF, et al: The cell growth suppressor, mir-126, targets IRS-1. Biochem Biophys Res Commun 377: 136-140, 2008.
20. Felli N, Felicetti F, Lustri AM, et al: miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 8: e56824, 2013.
21. Miko E, Margitai Z, Czimmerer Z, et al: miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. FEBS Lett 585: 1191-1196, 2011.
22. Glover DM, Hagan IM and Tavares AA: Polo-like kinases: a team that plays throughout mitosis. Genes Dev 12: 3777-3787, 1998. (Pubitemid 29024839)
23. Nigg EA: Polo-like kinases: positive regulators of cell division from start to finish. Curr Opin Cell Biol 10: 776-783, 1998.
24. Warnke S, Kemmler S, Hames RS, et al: Polo-like kinase-2 is required for centriole duplication in mammalian cells. Curr Biol 14: 1200-1207, 2004. (Pubitemid 38893984)
25. Burns TF, Fei P, Scata KA, Dicker DT and El-Deiry WS: Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells. Mol Cell Biol 23: 5556-5571, 2003. (Pubitemid 36951322)
26. Eckerdt F, Yuan J and Strebhardt K: Polo-like kinases and oncogenesis. Oncogene 24: 267-276, 2005. (Pubitemid 40188607)
27. Li Z, Lu J, Sun M, et al: Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 105: 15535-15540, 2008.
28. Oglesby IK, Bray IM, Chotirmall SH, et al: miR-126 is down-regulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol 184: 1702-1709, 2010.
29. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005. (Pubitemid 40372904)
30. Ueda T, Volinia S, Okumura H, et al: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146, 2010.
31. Shi H, Xu J, Zhang G, et al: Walking the interactome to identify human miRNA-disease associations through the functional link between miRNA targets and disease genes. BMC Syst Biol 7: 101, 2013.
32. Zhang M, Zhou S, Zhang L, et al: miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. FEBS Lett 586: 3508-3521, 2012.
33. Abell K, Bilancio A, Clarkson RW, et al: Stat3-induced apoptosis requires a molecular switch in PI (3) K subunit composition. Nat Cell Biol 7: 392-398, 2005. (Pubitemid 40533129)
34. De Gregorio G, Coppa A, Cosentino C, et al: The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals. Oncogene 26: 2039-2047, 2007. (Pubitemid 46514747)
35. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL and Reddy SA: The PI 3-kinase/Akt signaling pathway is activated due to aberrant Pten expression and targets transcription factors NF-kappaB and c-Myc in pancreatic cancer cells. Oncogene 23: 8571-8580, 2004. (Pubitemid 39576463)